Minnesota's Solventum sells purification business to Thermo Fisher for $4.1 billion
M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said in a news release that the sale,
In $4.1B deal, Thermo Fisher buys 3M spinoff's filtration unit to beef up bioproduction
On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics production business through a $4.1 billion acquisition. | On the heels of a move to reduce its viral vector manufacturing workforce,
The price of bitcoin fell below $90,000 and other cryptocurrencies saw large drops Tuesday morning, erasing some of the gains ...
Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback